Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Unisys Corporation (NYSE:UIS)

Unisys Corporation (NYSE:UIS) shareholders have witnessed a decrease in activity from the world’s largest hedge funds lately.

In today’s marketplace, there are plenty of indicators market participants can use to monitor Mr. Market. A couple of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the top fund managers can trounce their index-focused peers by a superb amount (see just how much).

Unisys Corporation (NYSE:UIS)

Just as key, optimistic insider trading sentiment is another way to parse down the investments you’re interested in. Obviously, there are plenty of incentives for a corporate insider to drop shares of his or her company, but just one, very obvious reason why they would behave bullishly. Many empirical studies have demonstrated the impressive potential of this tactic if shareholders know where to look (learn more here).

With these “truths” under our belt, it’s important to take a gander at the recent action regarding Unisys Corporation (NYSE:UIS).

What does the smart money think about Unisys Corporation (NYSE:UIS)?

In preparation for this year, a total of 17 of the hedge funds we track were long in this stock, a change of -11% from one quarter earlier. With hedgies’ sentiment swirling, there exists a few key hedge fund managers who were boosting their holdings significantly.

According to our comprehensive database, SAC Capital Advisors, managed by Steven Cohen, holds the largest position in Unisys Corporation (NYSE:UIS). SAC Capital Advisors has a $18 million position in the stock, comprising 0.1% of its 13F portfolio. Sitting at the No. 2 spot is James H. Litinsk of JHL Capital Group, with a $15 million position; the fund has 2.2% of its 13F portfolio invested in the stock. Some other peers that hold long positions include Chuck Royce’s Royce & Associates, Cliff Asness’s AQR Capital Management and Israel Englander’s Millennium Management.

Since Unisys Corporation (NYSE:UIS) has experienced falling interest from hedge fund managers, it’s safe to say that there lies a certain “tier” of money managers who sold off their entire stakes heading into 2013. At the top of the heap, Robert Millard’s Realm Partners sold off the largest investment of all the hedgies we key on, valued at an estimated $2 million in stock., and Peter Algert and Kevin Coldiron of Algert Coldiron Investors was right behind this move, as the fund dropped about $2 million worth. These transactions are interesting, as total hedge fund interest fell by 2 funds heading into 2013.

How have insiders been trading Unisys Corporation (NYSE:UIS)?

Insider buying is particularly usable when the company in question has experienced transactions within the past six months. Over the latest 180-day time period, Unisys Corporation (NYSE:UIS) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

With the returns demonstrated by the aforementioned tactics, retail investors must always keep an eye on hedge fund and insider trading sentiment, and Unisys Corporation (NYSE:UIS) is an important part of this process.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!